Hip Denervation in Juvenile Idiopathic Arthritis With Hip Arthritis

Hip Denervation in Juvenile Idiopathic Arthritis

Patients having juvenile idiopathic arthritis (according to ILAR criteria) with hip arthritis were divided into 3 groups. Group 1 received hip denervation and group 2 controlled and received a subcutaneous injection of saline, and group 3 received intra-articular triamcinolone. Outcome measures included pain, tenderness, range of motion, SOLAR, HARISS score. These outcomes were measured at baseline, 2 weeks, and 16 weeks

The aim of the study is to test the effect of denervation of the active hip in JIA and compare it with a placebo without changing systemic treatment during the study. Outcome measures included pain, range of motion, SOLAR score, and Harris functional score.

Inclusion Criteria:

• patients with JIA with unilateral hip arthritis

Exclusion Criteria:

• hip involvement due to other causes including
• septic arthritis
• other connective tissue diseases
• Avascular necrosis